Krug A - Search Results

1

New preclinical models for angioimmunoblastic T-cell lymphoma: filling the GAP.

Mhaidly R, Krug A, Gaulard P, Lemonnier F, Ricci JE, Verhoeyen E. Mhaidly R, et al. Among authors: krug a. Oncogenesis. 2020 Aug 14;9(8):73. doi: 10.1038/s41389-020-00259-x. Oncogenesis. 2020. PMID: 32796826 Free PMC article. Review.

2

Baboon Envelope Pseudotyped "Nanoblades" Carrying Cas9/gRNA Complexes Allow Efficient Genome Editing in Human T, B, and CD34⁺ Cells and Knock-in of AAV6-Encoded Donor DNA in CD34⁺ Cells.

Gutierrez-Guerrero A, Abrey Recalde MJ, Mangeot PE, Costa C, Bernadin O, Périan S, Fusil F, Froment G, Martinez-Turtos A, Krug A, Martin F, Benabdellah K, Ricci EP, Giovannozzi S, Gijsbers R, Ayuso E, Cosset FL, Verhoeyen E. Gutierrez-Guerrero A, et al. Among authors: krug a. Front Genome Ed. 2021 Feb 9;3:604371. doi: 10.3389/fgeed.2021.604371. eCollection 2021. Front Genome Ed. 2021. PMID: 34713246 Free PMC article.

3

Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and CAR-Based Anti-Cancer Therapies.

Krug A, Martinez-Turtos A, Verhoeyen E. Krug A, et al. Cancers (Basel). 2021 Dec 30;14(1):183. doi: 10.3390/cancers14010183. Cancers (Basel). 2021. PMID: 35008348 Free PMC article. Review.

4

Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity.

Bernard PL, Delconte R, Pastor S, Laletin V, Costa Da Silva C, Goubard A, Josselin E, Castellano R, Krug A, Vernerey J, Devillier R, Olive D, Verhoeyen E, Vivier E, Huntington ND, Nunes J, Guittard G. Bernard PL, et al. Among authors: krug a. J Immunother Cancer. 2022 May;10(5):e004244. doi: 10.1136/jitc-2021-004244. J Immunother Cancer. 2022. PMID: 35589278 Free PMC article.

5

Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality.

Krug A, Tari G, Saidane A, Gaulard P, Ricci JE, Lemonnier F, Verhoeyen E. Krug A, et al. Cancers (Basel). 2022 May 12;14(10):2392. doi: 10.3390/cancers14102392. Cancers (Basel). 2022. PMID: 35625998 Free PMC article. Review.

6

IRE1α overexpression in malignant cells limits tumor progression by inducing an anti-cancer immune response.

Martinez-Turtos A, Paul R, Grima-Reyes M, Issaoui H, Krug A, Mhaidly R, Bossowski JP, Chiche J, Marchetti S, Verhoeyen E, Chevet E, Ricci JE. Martinez-Turtos A, et al. Among authors: krug a. Oncoimmunology. 2022 Aug 27;11(1):2116844. doi: 10.1080/2162402X.2022.2116844. eCollection 2022. Oncoimmunology. 2022. PMID: 36046811 Free PMC article.

7

Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia.

Muselli F, Mourgues L, Rochet N, Nebout M, Guerci A, Verhoeyen E, Krug A, Legros L, Peyron JF, Mary D. Muselli F, et al. Among authors: krug a. Cancers (Basel). 2023 Feb 3;15(3):995. doi: 10.3390/cancers15030995. Cancers (Basel). 2023. PMID: 36765952 Free PMC article.

8

Nanoblades allow high-level genome editing in murine and human organoids.

Tiroille V, Krug A, Bokobza E, Kahi M, Bulcaen M, Ensinck MM, Geurts MH, Hendriks D, Vermeulen F, Larbret F, Gutierrez-Guerrero A, Chen Y, Van Zundert I, Rocha S, Rios AC, Medaer L, Gijsbers R, Mangeot PE, Clevers H, Carlon MS, Bost F, Verhoeyen E. Tiroille V, et al. Among authors: krug a. Mol Ther Nucleic Acids. 2023 Jun 8;33:57-74. doi: 10.1016/j.omtn.2023.06.004. eCollection 2023 Sep 12. Mol Ther Nucleic Acids. 2023. PMID: 37435135 Free PMC article.

9

Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment.

Krug A, Tosolini M, Madji Hounoum B, Fournié JJ, Geiger R, Pecoraro M, Emond P, Gaulard P, Lemonnier F, Ricci JE, Verhoeyen E. Krug A, et al. J Exp Clin Cancer Res. 2024 Feb 6;43(1):43. doi: 10.1186/s13046-024-02952-w. J Exp Clin Cancer Res. 2024. PMID: 38321568 Free PMC article.

10

Differences in the neural correlates of schizophrenia with positive and negative formal thought disorder in patients with schizophrenia in the ENIGMA dataset.

Sharkey RJ, Bacon C, Peterson Z, Rootes-Murdy K, Salvador R, Pomarol-Clotet E, Karuk A, Homan P, Ji E, Omlor W, Homan S, Georgiadis F, Kaiser S, Kirschner M, Ehrlich S, Dannlowski U, Grotegerd D, Goltermann J, Meinert S, Kircher T, Stein F, Brosch K, Krug A, Nenadic I, Sim K, Spalletta G, Banaj N, Sponheim SR, Demro C, Ramsay IS, King M, Quidé Y, Green MJ, Nguyen D, Preda A, Calhoun V, Turner J, van Erp T, Nickl-Jockschat T. Sharkey RJ, et al. Among authors: krug a. Mol Psychiatry. 2024 Apr 26. doi: 10.1038/s41380-024-02563-z. Online ahead of print. Mol Psychiatry. 2024. PMID: 38671214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

446 results

Search Page